Indeed, tumor-infiltrated CD14+ cDCs express higher levels of TAM-related markers such as CD206, MerTK, and CD163 compared with blood-circulating CD14+ cDCs in melanoma patients [82]. The gene discussed is CD14; the disease is neoplasm.